The ready-to-use lentiviral particles of Lenti-MAGE-A3 TCR (6F9)-VP is packaged using 3rd generation of lentiviral packaging system, in which the gene of Human TCR will be driven by a CMV promotor. The target gene of TCR packaged in lentiviral particles could be used for high efficency tranduction of T cells and stably integrated expression.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
|TCR-L059Z||Murinized anti-MAGEA3 (aa243-258) T cell receptor, pCDTCR1|
|TCR-C123Z||Human anti-MAGE-A3 T cell receptor (A10), pCDTCR1|
|TCR-L061Z||Human anti-MAGEA3 (aa168-176) T cell receptor, pCDTCR1|
|VP-TCR-C239||Lenti-MAGE-A3 (KVAELVHFL) T cell receptor (Affinity enhanced) Viral Particle|
|TCR-C129Z||Human anti-MAGE-A3 T cell receptor (TCRVα38/Vβ2), pCDTCR1|
|TCR-C119Z||Human anti-MAGE-A3 T cell receptor (MAG-IC3), pCDTCR1|
|TCR-L060||Murinized (from Human) anti-MAGEA3 (KKLLTQHFVQENYLEY) T Cell Receptor, pMSGV1|
|VP-TCR-C248||Lenti-MAGE-A3 (KVAELVHFL) T cell receptor Viral Particle|
|VP-TCR-C242||Lenti-MAGE-A3 (EVDPIGHLY) T cell receptor (Affinity enhanced) Viral Particle|
|TCR-L359||Human anti-MAGE-A3 T cell receptor (EB81-103), pCDTCR1|
Copyright © 2007 - 2018 Creative Biolabs. All Rights Reserved